AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow CME
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M. J.
Right arrow Articles by Oh, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M. J.
Right arrow Articles by Oh, K. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.2714
AJR 2008; 190:208-213
© American Roentgen Ray Society


Clinical Observations

Bilateral Synchronous Breast Cancer in an Asian Population: Mammographic and Sonographic Characteristics, Detection Methods, and Staging

Min Jung Kim1, Eun-Kyung Kim1, Jin Young Kwak1, Byeong-Woo Park2, Seung-Il Kim2 and Ki Keun Oh1

1 Department of Diagnostic Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, Seoul 120-752, South Korea.
2 Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea.

Received January 16, 2007; accepted after revision July 3, 2007.

 
Address correspondence to E. K. Kim (ekkim{at}yuhs.ac).

Supported by the Students' Association of the Graduate School of Yonsei University and funded by the Graduate School of Yonsei University.

CME This article is available for CME credit. See www.arrs.org for more information.

FOR YOUR INFORMATION

This article is available for CME credit. See www.arrs.org for more information.


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. This study was performed to compare the clinical and radiologic findings and pathologic staging between index cancer and contralateral synchronous breast cancers and to determine the roles of mammography and sonography in their detection.

CONCLUSION. Additional contralateral breast cancers in bilateral synchronous breast cancers are apt to be small and less palpable and to have less suspicious imaging findings and less advanced cancer staging than the index cancer. Bilateral whole-breast sonography with mammography is useful in the early detection of contralateral synchronous breast cancer.

Keywords: bilateral breast cancer • breast cancer • mammography • synchronous cancer • sonography


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The overall incidence of bilateral breast cancer has been shown to range from 1.4% to 12% [1-4]. The incidence of bilateral synchronous breast cancer is uncommon, ranging from 0.7% to 3.0% in recent reports [2, 3, 5], and patients with bilateral synchronous breast cancer have worse survival rates because of distant metastasis [3]. Detection of bilateral synchronous breast cancer on mammography has been associated with earlier stage on diagnosis and better survival than the index cancer [6-8]. These findings reinforce the need for early detection of nonsymptomatic contralateral breast cancer in patients at the time of the initial diagnosis of unilateral breast cancer. It has been reported that bilateral whole-breast sonography could depict mammographically and clinically unsuspected cancers in the contralateral breast and in the ipsilateral breast [9].

The purpose of this study was to compare the clinical, radiologic, and pathologic findings of index and contralateral cancers of bilateral synchronous breast cancers and to retrospectively determine the role of mammography and bilateral whole-breast sonography in the detection of contralateral cancers.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Our institutional review board approved our research study and waived the informed consent requirement because this was a retrospective study.

Study Population
The medical records of all patients who underwent surgery for primary breast cancer at our institution during the period 2000 through 2006 were retrospectively reviewed. Between September 2000 and July 2006, 2,465 cases of stages 0-III primary breast carcinomas, as defined by the American Joint Committee for Cancer (AJCC) [10], were treated by either mastectomy or breast conservation therapy at the department of general surgery at our institution. Of those 2,465 cancers in 2,419 patients, 72 cancers in 36 patients were classified as bilateral synchronous breast cancer. The lesions were considered synchronous if they were diagnosed within 6 months. Ten cancers in five patients, for which preoperative mammography or sonography was not available, were excluded, and the remaining 62 cancers in 31 patients made up the material for the comparison of imaging findings. These 31 patients had undergone both mammography and bilateral whole-breast sonography in their preoperative evaluations. The contralateral synchronous cancers were detected at a clinical examination or preoperative imaging evaluation.

Imaging Evaluation
Mammography was performed with dedicated equipment (DMR, GE Healthcare) until April 2005, and with the Selenia Full-Field Digital Mammography System (Lorad/Hologic) from May 2005 until the present. Standard craniocaudal and mediolateral oblique views were routinely obtained, and additional mammographic views were obtained as needed. Bilateral whole-breast sonography has been prospectively performed in the preoperative evaluation of a patient with a known breast malignancy or in the diagnostic evaluation of a patient with a suspicion of breast cancer in our institution since 2000. Sonography was performed using ATL HDI 5000 and 3000 (Philips Medical Systems) sonography units with 10-MHz of linear array transducers by two full-time board-certified radiologists having 4 and 10 years of experience in performing breast sonography and in interpreting both breast sonography and mammography. One of the two radiologists reviewed the record of the imaging studies to gather category classification, and the other radiologist reviewed imaging findings.

The BI-RADS categories of mammographic and sonographic findings [11] were used in category classification of the original radiology reports. The original reports were not reread to rule out the possibility that foreknowledge of the correct cancer diagnosis might affect reinterpretation and to ensure that the results would reflect the accuracy of routine diagnostic work. Although the sonography BI-RADS lexicon did not exist before 2003, sonographic findings at our institution had been categorized according to the risk of malignancy similar to mammographic BI-RADS categories since 1999. Before 2003, we had subclassified category 4 into categories 4a and 4b, and regarded category 4b as category 4c of the published sonography BI-RADS lexicons with respect to the risk of malignancy. Since 2003, we have subclassified category 4 into categories 4a, 4b, and 4c. However, category 4b classified after 2003 was preserved as category 4b. Mammographic findings were classified as either mass, mass with microcalcifications, microcalcifications only, focal asymmetry, and architectural distortion, if any abnormality was detected. The sonographic findings were classified according to lexicon of the American College of Radiology BI-RADS [11].

Data Analysis
We defined the index cancer as the mass that was initially detected or reported by a patient, and contralateral cancer was defined as the mass that was detected in the contralateral breast during breast evaluation. When the patient complained of palpable bilateral masses, we regarded the mass that was palpated first as the index breast cancer. If both the bilateral masses were asymptomatic, we defined the earlier reported mass as the index breast cancer. We evaluated clinical and pathologic findings in index and contralateral cancers; assessed the detection method of all bilateral synchronous breast cancer cases; and compared the clinical, mammographic, sonographic, and pathologic findings with each other. For the size of the breast cancer, we evaluated the invasive cancer only, excluding in situ lesions. The sensitivities of mammography and sonography were compared.

Statistical comparisons were performed using the Mantel-Haenszel chi-square test for pathologic staging and BI-RADS categorization, the chisquare or Fisher's exact tests for other nonparametric variables, and the Student's t-test for parametric inference. Statistical analysis was performed with the SAS system (MAGREE SAS Macro program).


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Clinical and Pathologic Findings
The 31 women in the study ranged in age from 33 to 65 years (mean age, 49 years; median, 49 years) at the time of the diagnosis of bilateral breast cancer. They were referred for breast examination for the following reasons: a palpable mass in 25 patients (81%), of whom six patients had known breast malignancy proven pathologically in other hospitals; nipple discharge in one patient (3%); positive findings at screening mammography in three patients (10%); and sonographic screening for dense breasts in two patients (6%). Of the 25 patients with palpable lumps, six complained of bilateral palpable breast masses.

The contralateral cancers were more often nonpalpable (84%) than the index cancers (16%), and the difference was statistically significant (p < 0.0001) (Table 1). The contralateral cancers significantly included more cases of ductal carcinoma in situ (DCIS) (45.2%) than the index cancers (9.7%; p = 0.01) (Tables 1 and 2).


View this table:
[in this window]
[in a new window]

 
TABLE 1: AJCC Stages of 62 Bilateral Synchronous Breast Cancers in 31 Patients

 

View this table:
[in this window]
[in a new window]

 
TABLE 2: Distribution of Histologic Subtypes of Breast Cancers in 31 Patients with Bilateral Breast Cancer

 

The mean pathologic size of all invasive cancers was 2.2 cm (range, 0.2-12.0 cm; median, 1.7 cm). The contralateral cancers were smaller (mean size, 1.5 cm; median, 1.2 cm; SD, 0.7 cm) than the index cancers (mean size, 2.6 cm; median, 2.4 cm; SD, 2.2 cm; p = 0.04). Seven percent of the index cancers were 1.0 cm or less in diameter compared with 40% of the contralateral cancers (p = 0.02). Table 2 summarizes the distribution of histologic subtypes of the bilateral breast cancers. In the two patients with invasive lobular carcinoma as the index cancer, the contralateral cancers were also invasive lobular carcinoma.


Figure 1
View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A —49-year-old woman with palpable lump in subareolar portion of right breast. Craniocaudal mammogram shows round hyperdense mass (arrow) in right breast but no focal lesions in left breast.

 


Figure 2
View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B —49-year-old woman with palpable lump in subareolar portion of right breast. Sonogram shows 4-cm round, hypoechoic nodule with microlobulated margin and adjacent edematous changes at corresponding portion of breast.

 


Figure 3
View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C —49-year-old woman with palpable lump in subareolar portion of right breast. Bilateral whole-breast sonogram also shows 1-cm irregular, microlobulated, hypoechoic nodule in lower portion of left breast. Automated core biopsy revealed infiltrating ductal carcinoma in both breasts.

 
Detection Methods and Their Sensitivity
Table 3 summarizes the sensitivity of mammography and sonography in the index and contralateral cancers in relation to their palpation findings. The overall sensitivity of mammography was 87% (27/31 cases) in index cancers and 55% (17/31 cases) in contralateral cancers (p = 0.011). The sensitivity of mammography was significantly lower in the detection of nonpalpable contralateral cancers than the detection of nonpalpable and palpable index breast cancers (p = 0.01). The overall sensitivity of sonography was 97% (30/31 cases) in index cancers and was not significantly different from that of contralateral cancers (90%, 28/31 cases; p = 0.61). The sensitivity of sonography was significantly higher than that of mammography in the detection of contralateral cancers (p = 0.003) and nonpalpable contralateral cancers (p = 0.002). Moreover, in the 13 contralateral cancers detected on sonography only, eight cancers (61.5%) were DCIS.


View this table:
[in this window]
[in a new window]

 
TABLE 3: Comparison of Mammographic and Sonographic Sensitivities with Palpation Findings in Index and Contralateral Cancers

 

Among 14 cases of contralateral DCIS, four, including one palpable lesion, showed positive results at both mammography and sonography. Although two DCIS showing microcalcifications were detected on mammography only, and the remaining eight (57%) were found on sonography only, all manifested as masses. Of four DCIS showing positive results on both mammography and sonography, three manifested only as microcalcifications in a dense breast on mammography but revealed combined masses on sonography.

Imaging Findings
Table 4 summarizes the imaging findings and BI-RADS categorization in 62 bilateral breast cancers. The index and contralateral cancers showed statistically significant differences in the mammographic presentation (p = 0.007, Fig. 1A, 1B, 1C), BI-RADS final assessment (p < 0.001), sonographic boundary (p = 0.038), and posterior echogenicity (p = 0.005), but no significant differences in other sonographic findings, including shape (p = 0.210), margin (p = 0.155), orientation (p = 0.522), internal echogenicity (p = 0.330), and calcifications (p = 0.306). No statistically significant differences were noted in mammographic parenchymal pattern (p = 1.0) because all of our patients except one had heterogeneously dense or extremely dense breasts and the bilateral mammograms were performed simultaneously.


View this table:
[in this window]
[in a new window]

 
TABLE 4: Imaging Findings and BI-RADS Category for 62 Bilateral Breast Cancers

 


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The incidence of bilateral synchronous breast cancer has been reported variably according to its definition [2, 3, 5, 7, 12]. The interest in bilateral synchronous breast cancer has increased because the incidence of this cancer is expected to rise as a direct result of improved detection capabilities [1, 3]. Furthermore, the survival rate of patients with bilateral synchronous breast cancer is worse than that of those with unilateral breast cancer [3, 7, 12, 13].

In this study, contralateral cancers tended to be smaller and to have DCIS in a higher percentage of the cases than the index cancer, which is consistent with previous reports. A large portion of index cancers in our patients were detected by palpation (81%, 25/31 patients). This high percentage is unusual in this era of screening, although Hungness et al. [6] also reported 81% of index cancers in their bilateral synchronous breast cancers were diagnosed by palpation (30/37 cases). In a review of the literature, we could not find any other reports about the mode of detection of the index cancer. One of the possible reasons for this high palpability rate in our study is that mammographic screening has just become common in recent years in our country. Second, breast parenchyma in our mammographic examinations showed dense parenchymal tissue in all but one patient. Our patients were approximately 10 years younger than those in previous studies [3, 8, 14, 15], so their mammographic sensitivity might be lower. The third is ethnic differences. Because breast size in Asian American women is reported to be significantly smaller than that in white women [16], we suggest that the small breast volume of the Asian women who were included in our study would reflect a higher rate of palpability. Despite the high rate of palpability, the index cancers in our study were pathologically less than stage 1 in 41.9% (13/31) of patients, which is comparable to the 49.4% in the study by Heron et al. [3] (n = 47), and 68% of palpable index cancers (17/25 patients) were DCIS or stage 1 cancer.

In several previous reports of patients with bilateral breast cancer, the contralateral cancer was small and frequently detected on mammography [6-8]. Murphy et al. [17] reported that bilateral breast cancers frequently showed a similar mammographic appearance to the index cancer and mirror image locations, whereas Roubidoux et al. [14] reported that the contralateral tumors usually have major mammographic findings different from those of the first cancers, and that evaluation of a contralateral mammogram should be performed without regard for the mammographic findings of the first cancer. Our results showed that the most common major mammographic finding was mass with or without microcalcifications in the index cancer, whereas negative mammographic findings were the most common finding in the contralateral cancer. These results are in keeping with those by Roubidoux et al. in that the mammographic signs of the first cancer do not indicate the most likely appearance of cancer in the contralateral breast. As we mentioned, our data are derived from low mammographic sensitivity because of dense parenchymal tissue and the small size of the contralateral breast cancer. However, our results do not diminish the important role of mammography because two of our contralateral cancers manifested microcalcifications on mammograms but showed negative findings on sonograms. Mammography is undoubtedly the cornerstone of breast evaluation.

Saarela et al. [15] compared the results of mammography and sonography for unilateral and bilateral breast cancer; however, they reported 60% sensitivity for sonography in the detection of breast cancer but they did not evaluate the sonography findings. Because standardized terminology such as BI-RADS lexicon did not exist when Saarela et al. reported their work, it was difficult to compare the sonography findings between the unilateral and contralateral breast cancers. We suggest that our results constitute the first report on sonographic findings of bilateral breast cancer and that the appearance of contralateral synchronous breast cancer does not differ from that of the index cancer except for the posterior echogenicity and boundary. However, the final BI-RADS assessment of the contralateral cancer tended to show less suspicious findings than that of the index cancer (p < 0.001), probably because of the smaller tumor size, the smaller amount of posterior shadowing, and fewer palpation findings.

Our results also suggest that sonography of contralateral breasts in patients with breast cancer needs to be approached with more caution than in patients without known breast cancer, and that we should search for any subtle suspicious findings during sonography in these patients. Moon et al. [9] reported that bilateral whole-breast sonography could depict mammographically and clinically unsuspected cancers in the contralateral and ipsilateral breasts. Their result of 12.5% of additional malignant foci found only on bilateral whole-breast sonography supports our results. Our retrospective review of the bilateral synchronous breast cancers that underwent bilateral whole-breast sonography confirmed that sonography had an important role in detecting the contralateral breast cancer.

One of our contralateral cancers was detected on breast MRI, and second-look sonography showed a microlobulated nodule corresponding to the lesion identified on MRI. MRI of the breast shows great promise as a preoperative planning procedure for defining the extent of cancer in the breast and detecting contralateral breast cancer; bilateral whole-breast sonography can be time-consuming and operator-dependent. Berg et al. [18] reported that the combination of MRI, mammography, and clinical examination in the identification of tumor foci was better that any other combinations of tests.

Several reports have indicated that the rate of mammographically and clinically occult contralateral cancers detected on MRI ranged from 3.1% to 11% [19-23]; moreover, some contralateral cancers included sonographically occult cancers [20, 22]. Thus, MRI may be more sensitive in identifying the second, contralateral cancer than sonography and mammography. However, MRI presents some practical limitations: difficulty in interpretation and sampling of lesions depicted only on MRI for biopsy, and the simultaneous evaluation of the contralateral breast requiring technical support such as parallel imaging for bilateral high-resolution MRI [24, 25]. Otherwise, the evaluation of the contralateral breast needs two patient visits and two contrast injections for bilateral sagittal imaging. In our patients, 61.5% of contralateral cancers detected on sonography only were DCIS. The sensitivity of MRI for detecting DCIS is 40-100% [26], so we were not sure that all of the in situ cancers detected only on sonography in our study would be found on MRI.

Patients with bilateral synchronous breast cancer have lower survival rates because of distant metastases, but these results are based on data from one to four decades ago [3, 4, 7, 8, 12]. Although the detection of bilateral synchronous breast cancer on mammography has also been reported to be associated with earlier stage at diagnosis and better survival [7, 8], our study, which was supported by high-resolution sonography, had far fewer palpable bilateral synchronous breast cancers (19%) and much more in situ bilateral synchronous breast cancer (45%) than previous studies (25-35%, 22-26%, respectively) of the early detection of bilateral synchronous breast cancer with mammography [7, 8]. In addition, to prove the survival benefit of bilateral whole-breast sonography, reevaluation of the survival rate in patients with bilateral synchronous breast cancer using sonography-detected contralateral cancer will be needed.

Our study has some limitations. First, the size of our series was too small to make a conclusive inference. Second, our study was done as a retrospective review, so we could not assess the positive predictive value and false-positive biopsy rate of bilateral whole-breast sonography. Further prospective analysis of a larger population to determine the sensitivity, specificity, and positive predictive value for call-backs, for additional imaging, and for biopsy recommendations will be required to evaluate and compare the true accuracy of each detection method. Third, all of our study population consisted of Asian women. Because the breast size in Asian American women is reported to be significantly smaller than that in white women [16], bilateral whole-breast sonography may be easier to perform in Asian women. That our study population consists of all Asian women could affect our results and act as a selection bias. Therefore, further study should be performed with various ethnic groups to generalize our results to other populations.

In conclusion, additional contralateral breast cancers in bilateral synchronous breast cancers tend to be small and less palpable and to manifest as less suspicious imaging findings with a less advanced cancer stage. Our study suggests that bilateral whole-breast sonography with mammography contributes to the early detection of the contralateral cancer of bilateral synchronous breast cancer.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 1984; 71:711 -714[Medline]
  2. El Hanchi Z, Berrada R, Fadli A, et al. Bilateral breast cancer: incidence and risk factors [in French]. Gynecol Obstet Fertil 2004; 32:128 -134[CrossRef][Medline]
  3. Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer2000; 88:2739 -2750[CrossRef][Medline]
  4. Al-Jurf AS, Jochimsen PR, Urdaneta LF, Scott DH. Factors influencing survival in bilateral breast cancer. J Surg Oncol 1981; 16:343 -348[CrossRef][Medline]
  5. Cody HS 3rd. Routine contralateral breast biopsy: helpful or irrelevant? Experience in 871 patients, 1979-1993. Ann Surg 1997; 225:370 -376[CrossRef][Medline]
  6. Hungness ES, Safa M, Shaughnessy EA, et al. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the two breasts. Surgery 2000;128 : 702-707[CrossRef][Medline]
  7. Polednak AP. Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery 2003; 133:383 -389[CrossRef][Medline]
  8. Roubidoux MA, Helvie MA, Lai NE, Paramagul C. Bilateral breast cancer: early detection with mammography. Radiology1995; 196:427 -431[Abstract/Free Full Text]
  9. Moon WK, Noh DY, Im JG. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients. Radiology 2002;224 : 569-576[Abstract/Free Full Text]
  10. American Joint Committee on Cancer. AJCC cancer staging manual, 6th ed. Philadelphia, PA: Lippincott-Raven,2002
  11. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS). Reston, VA: ACR,2003
  12. Carmichael AR, Bendall S, Lockerbie L, Prescott R, Bates T. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. Eur J Surg Oncol2002; 28:388 -391[CrossRef][Medline]
  13. Pomerantz RA, Murad T, Hines JR. Bilateral breast cancer. Am Surg 1989; 55:441 -444[Medline]
  14. Roubidoux MA, Lai NE, Paramagul C, Joynt LK, Helvie MA. Mammographic appearance of cancer in the opposite breast: comparison with the first cancer. AJR 1996;166 : 29-31[Abstract/Free Full Text]
  15. Saarela AO, Rissanen TJ, Kiviniemi HO, Paloneva TK. Mammographic and ultrasonographic findings in bilateral breast cancer: a comparative study. Eur Radiol 1998;8 : 634-638[CrossRef][Medline]
  16. Chen Z, Wu AH, Gauderman WJ, et al. Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol 2004; 159:140 -147[Abstract/Free Full Text]
  17. Murphy TJ, Conant EF, Hanau CA, Ehrlich SM, Feig SA. Bilateral breast carcinoma: mammographic and histologic correlation. Radiology 1995;195 : 617-621[Abstract/Free Full Text]
  18. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology2004; 233:830 -849[Abstract/Free Full Text]
  19. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213 : 881-888[Abstract/Free Full Text]
  20. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology2000; 215:267 -279[Abstract/Free Full Text]
  21. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR 2003; 180:333 -341[Abstract/Free Full Text]
  22. Rieber A, Merkle E, Bohm W, Brambs HJ, Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997;21 : 773-779[CrossRef][Medline]
  23. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007;356 : 1295-1303[Abstract/Free Full Text]
  24. Friedman PD, Swaminathan SV, Smith R. SENSE imaging of the breast. AJR 2005; 184:448 -451[Free Full Text]
  25. Friedman PD, Swaminathan SV, Herman K, Kalisher L. Breast MRI: the importance of bilateral imaging. AJR2006; 187:345 -349[Free Full Text]
  26. Ikeda DM, Birdwell RL, Daniel BL. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection. Magn Reson Imaging Clin N Am 2001;9 : 345-356, vii[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
M. J. Kim, E.-K. Kim, J. Y. Kwak, B.-W. Park, S.-I. Kim, J. Sohn, and K. K. Oh
Sonographic Surveillance for the Detection of Contralateral Metachronous Breast Cancer in an Asian Population
Am. J. Roentgenol., January 1, 2009; 192(1): 221 - 228.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. J. Kim, E.-K. Kim, J. Y. Kwak, B.-W. Park, S.-I. Kim, J. Sohn, and K. K. Oh
Role of Sonography in the Detection of Contralateral Metachronous Breast Cancer in an Asian Population
Am. J. Roentgenol., February 1, 2008; 190(2): 476 - 480.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow CME
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M. J.
Right arrow Articles by Oh, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M. J.
Right arrow Articles by Oh, K. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS